Overview

the Pharmacokinetic Profiles of Linagliptin With DW1029M

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Phase I clinical study to evaluate DW1029M influence the pharmacokinetic profiles of Linagliptin after oral administration in healthy male volunteer.
Phase:
Phase 1
Details
Lead Sponsor:
Dong Wha Pharmaceutical Co. Ltd.
Treatments:
Linagliptin